anticancer liposome injection (SSY Group)

N/A

Report date: 2025/01/26 16:20:05
NME

Base Information

Drug Nameanticancer liposome injection (SSY Group)
Drug Alias Namemiriplatin (SSY Group)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShisiyao Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShisiyao Group Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A